UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 65 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,000 | -65.3% | 11,772 | -29.8% | 0.00% | – |
| Q1 2021 | $101,000 | +20.2% | 16,776 | +4.7% | 0.00% | – |
| Q4 2020 | $84,000 | +90.9% | 16,016 | +26.5% | 0.00% | – |
| Q3 2020 | $44,000 | -58.9% | 12,657 | +2.7% | 0.00% | -100.0% |
| Q2 2020 | $107,000 | +7.0% | 12,324 | -10.8% | 0.00% | – |
| Q4 2019 | $100,000 | +11.1% | 13,822 | -6.2% | 0.00% | -100.0% |
| Q3 2019 | $90,000 | -37.5% | 14,735 | -2.8% | 0.00% | 0.0% |
| Q2 2019 | $144,000 | +3.6% | 15,164 | -11.2% | 0.00% | 0.0% |
| Q1 2019 | $139,000 | -49.6% | 17,083 | +0.7% | 0.00% | -50.0% |
| Q4 2018 | $276,000 | – | 16,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $9,431,886,000 | 10.86% |
| Invus Financial Advisors, LLC | 1,094,998 | $6,570,000 | 1.51% |
| Founders Fund V Management, LLC | 491,751 | $2,951,000 | 0.16% |
| Arbor Wealth Management, LLC | 25,888 | $155,000 | 0.05% |
| PDT Partners, LLC | 70,233 | $421,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 575,443 | $3,453,000 | 0.03% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 18,644 | $112,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $60,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $22,818,000 | 0.01% |
| Summit Trail Advisors, LLC | 13,458 | $81,000 | 0.01% |